Cystinosis Clinical Trials

10 recruitingLast updated: June 18, 2026

There are 10 actively recruiting cystinosis clinical trials across 7 countries. Studies span Phase 1, Phase 2, Not Applicable. Top locations include Atlanta, Georgia, United States, Besançon, France, Bethesda, Maryland, United States. Updated daily from ClinicalTrials.gov.


Cystinosis Trials at a Glance

10 actively recruiting trials for cystinosis are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Phase 1 with 3 trials, with the heaviest enrollment activity in Atlanta, Besançon, and Bethesda. Lead sponsors running cystinosis studies include Cystinose Stiftung, Hospices Civils de Lyon, and Alice Bertaina.

Browse cystinosis trials by phase

Treatments under study

About Cystinosis Clinical Trials

Looking for clinical trials for Cystinosis? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cystinosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cystinosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Phase 1Phase 2

DFT383 in Pediatric Participants With Nephropathic Cystinosis

Nephropathic Cystinosis
Novartis Pharmaceuticals30 enrolled4 locationsNCT06910813
Recruiting

Use of Cysteamine in the Treatment of Cystinosis

Cystinosis
National Human Genome Research Institute (NHGRI)330 enrolled1 locationNCT00359684
Recruiting
Phase 1Phase 2

PK and PD Study of NPI-001 and Cysteamine Bitartrate

Cystinosis
Nacuity Pharmaceuticals, Inc.12 enrolled1 locationNCT05994534
Recruiting

European Cystinosis Cohort

Cystinosis
Institut National de la Santé Et de la Recherche Médicale, France400 enrolled1 locationNCT05901077
Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Multiple Endocrine Neoplasia Type 1Multiple Endocrine Neoplasia Type 2Rare Disorders+337 more
Sanford Health20,000 enrolled2 locationsNCT01793168
Recruiting

CYSTEA-BONE Clinical Study

Nephropathic Cystinosis
Hospices Civils de Lyon50 enrolled13 locationsNCT03919981
Recruiting

Development of Health-related Quality of Life Instrument for Patients With Cystinosis

Cystinosis
Cystinose Stiftung300 enrolled1 locationNCT05959668
Recruiting

National Registry of Rare Kidney Diseases

Denys-Drash SyndromeTuberous SclerosisAutosomal Recessive Polycystic Kidney Disease+81 more
UK Kidney Association35,000 enrolled1 locationNCT06065852
Recruiting
Phase 1Phase 2

Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor

CystinosisCKD Stage 4FSGS+2 more
Alice Bertaina12 enrolled1 locationNCT05508009
Recruiting
Not Applicable

Genetic Newborn Screening for Cystinosis and Primary Hyperoxaluria

CystinosisPrimary Hyperoxaluria
Cystinose Stiftung200,000 enrolled1 locationNCT05843851